A detailed history of Praetorian Pr LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Praetorian Pr LLC holds 780,800 shares of INMB stock, worth $3.87 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
780,800
Previous 485,000 60.99%
Holding current value
$3.87 Million
Previous $4.28 Billion 1.62%
% of portfolio
1.64%
Previous 1.57%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.86 - $9.86 $1.44 Million - $2.92 Million
295,800 Added 60.99%
780,800 $4.21 Billion
Q2 2024

Aug 14, 2024

BUY
$7.15 - $11.84 $3.47 Million - $5.74 Million
485,000 New
485,000 $4.28 Billion

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $89M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Praetorian Pr LLC Portfolio

Follow Praetorian Pr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Praetorian Pr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Praetorian Pr LLC with notifications on news.